ADALIMUMAB, BARICITINIB, BARICITINIB, ADALIMUMAB, ETANERCEPT
I4V-MC-JAJA
Approved small_molecule active
Quick answer
ADALIMUMAB, BARICITINIB, BARICITINIB, ADALIMUMAB, ETANERCEPT for Rheumatoid Arthritis is a Approved program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Rheumatoid Arthritis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active